RealFeedApp Pharma companies historically prefer buying services over software
Sahir Raoof launched his first solo VC fund to invest in startups using AI to automate pharmaceutical drug development and clinical trial analysis.
- Field
- business and funding
- What they did
- Investor Sahir Raoof raised $27.5 million for his first VC fund to support startups using AI for drug development.
- Why it matters
- This could help pharmaceutical companies automate processes like compound synthesis and clinical trial analysis, reducing their reliance on external service providers.
#venture capital#ai#drug development#pharmaceuticals
